Search - tctmd.com

Displaying 221 - 240 of 867

Sort: Relevancy | Date

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

L.A. McKeown

March 27, 2024

News Daily News

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

Todd Neale

March 25, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

Presentation THT 2024

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Presenter: Kamile Cerlinskaite-Bajore

March 06, 2024

Presentation THT 2024

AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial

Presenter: Deya Alkhatib

March 06, 2024

Presentation THT 2024

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Presenter: Liviu Klein

March 05, 2024

Presentation THT 2024

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Presenter: David M. Kaye

March 05, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Presenter: Sanjiv J. Shah

March 05, 2024

Presentation THT 2024

The Pivotal ALIVE Trial of the Revivent TC Transcatheter Ventricular Enhancement System in Heart Failure Patients with Prior Anterior Myocardial Infarction

Presenter: Jerry D. Estep

March 05, 2024

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

BrioHealth Solutions: Pump and Clinical Trial Design

Presenter: James Long

March 04, 2024

Advertisement

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Biologic Winrevair Wins FDA Approval for Treatment of PAH

ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Semaglutide Winning Streak Continues in CKD With FLOW

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

The Pivotal ALIVE Trial of the Revivent TC Transcatheter Ventricular Enhancement System in Heart Failure Patients with Prior Anterior Myocardial Infarction

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Debating the Role of T-TEER in the Sickest Patients

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

BrioHealth Solutions: Pump and Clinical Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content